148 related articles for article (PubMed ID: 26263511)
21. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
[TBL] [Abstract][Full Text] [Related]
22. Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis.
Zhao K; Xu J; Tian H
Genet Mol Res; 2016 Mar; 15(1):15017021. PubMed ID: 26985948
[TBL] [Abstract][Full Text] [Related]
23. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
24. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
25. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
26. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
[TBL] [Abstract][Full Text] [Related]
27. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
Ma H; Shu Y; Pan S; Chen J; Dai J; Jin G; Hu Z; Shen H
Lung Cancer; 2011 Nov; 74(2):164-9. PubMed ID: 21514686
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
Yohena T; Yoshino I; Takenaka T; Kameyama T; Ohba T; Kuniyoshi Y; Maehara Y
J Thorac Oncol; 2009 Mar; 4(3):284-90. PubMed ID: 19190516
[TBL] [Abstract][Full Text] [Related]
30. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
[TBL] [Abstract][Full Text] [Related]
32. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer.
Koga F; Kageyama Y; Kawakami S; Fujii Y; Hyochi N; Ando N; Takizawa T; Saito K; Iwai A; Masuda H; Kihara K
J Urol; 2004 Mar; 171(3):1080-4. PubMed ID: 14767275
[TBL] [Abstract][Full Text] [Related]
34. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
Raspaglio G; Petrillo M; Martinelli E; Li Puma DD; Mariani M; De Donato M; Filippetti F; Mozzetti S; Prislei S; Zannoni GF; Scambia G; Ferlini C
Gene; 2014 Jun; 542(2):173-81. PubMed ID: 24661907
[TBL] [Abstract][Full Text] [Related]
35. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
36. The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer.
Cui E; Deng A; Wang X; Wang B; Mao W; Feng X; Hua F
Biochem Cell Biol; 2011 Jun; 89(3):308-13. PubMed ID: 21619462
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
[TBL] [Abstract][Full Text] [Related]
39. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]